Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.

导出 LinkOut

翻译打印收藏纠错

作者： Hiromi,Matsumoto ^[1] ; Nobuaki,Kobayashi ^[1] ; Kohei,Somekawa ^[1] ; Nobuhiko,Fukuda ^[1] ; Ayami,Kaneko ^[1] ; Chisato,Kamimaki ^[1] ; Sousuke,Kubo ^[1] ; Katsushi,Tanaka ^[1] ; Yoichi,Tagami ^[1] ; Shuhei,Teranishi ^[2] ; Keisuke,Watanabe ^[1] ; Nobuyuki,Horita ^[1] ; Yu,Hara ^[1] ; Masaki,Yamamoto ^[2] ; Makoto,Kudo ^[2] ; Harumi,Koizumi ^[3] ; Kenji,Miura ^[4] ; Naoki,Miyazawa ^[5] ; Takeshi,Kaneko ^[1]

作者单位： Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. ^[1] Respiratory Disease Center, Yokohama City University Medical Center, Yokohama, Japan. ^[2] Department of Pulmonology, Yokohama Minami Kyosai Hospital, Yokohama, Japan. ^[3] Respiratory Disease Center, Yokohama Sakae Kyosai Hospital, Yokohama, Japan. ^[4] Department of Pulmonology, Saiseikai Yokohamashi Nanbu Hospital, Yokohama, Japan. ^[5]

关键词 metastasis non-small-cell lung cancer pembrolizumab

主题词成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);中年人(Middle Aged);回顾性研究(Retrospective Studies)

DOI 10.1111/1759-7714.14252

PMID 34866339

发布时间 2022-02-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Thoracic cancer

2022年13卷2期

228-235页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.

Thoracic cancer

相似文献

Thoracic cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.

Thoracic cancer

相似文献

Thoracic cancer

相关期刊

检索历史清除